Itraconazole Pellets
Spheronised antifungal pellets ready for capsule filling, ensuring uniform azole distribution for systemic mycosis management.
Product overview
Itraconazole is a triazole antifungal used in pharmaceutical formulations. The pelletized format provides a practical multiparticulate platform for capsule manufacturing. Rraynex focuses on controlled coating, particle-size distribution, potency, residual-solvent monitoring, and pellet friability to support reproducible pharmaceutical processing.
Key characteristics
- Uniform active distribution.
- Controlled pellet morphology and sphericity.
- Suitable for capsule filling and multiparticulate dosage forms.
- Controlled residual-solvent and physical-quality parameters.
- Technical support for formulation development and commercial supply.
Product specifications
- Product
- Itraconazole Pellets
- Form
- Pellets
- Therapeutic category
- Anti-fungal
- Available strengths
- 20%, 22%, 40%, 44%
- Grade
- IP / BP / USP / EP
- Pack size
- 25/50 kg
- Site certifications
- WHO-GMP, ISO 9001, ISO 14001
Detailed specifications, COA and technical documentation are shared on request.
Supply and enquiries
Rraynex supplies Itraconazole Pellets to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.
Send product enquiry Browse all pellets Manufacturing capabilities
Other Itraconazole products from Rraynex
- Itraconazole IR (WW) — Pellets